Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
131.2 USD | +3.29% | +5.21% | +20.85% |
03:21pm | The specter of stagflation rears its ugly head again | |
02:53pm | Merck Lifts Full-Year 2024 Outlook Following First-Quarter Beat | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.85% | 322B | |
+23.48% | 562B | |
-5.45% | 358B | |
+8.88% | 297B | |
+13.25% | 219B | |
+6.63% | 199B | |
-10.10% | 196B | |
-8.93% | 149B | |
-5.12% | 146B | |
+2.12% | 117B |
- Stock Market
- Equities
- MRK Stock
- News Merck & Co., Inc.
- Merck : Abandons Development of COVID-19 Drug MK-7110